Johnson Craig A
SEC-identified person · CIK 1370348 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aurinia Pharmaceuticals Inc. AUPH | Director | filed 2024 - 2026 |
| Heron Therapeutics, INC. /DE/ appa | Director | filed 2014 - 2026 |
| Mirati Therapeutics, Inc. mrtx | Director | filed 2013 - 2024 |
| LA Jolla Pharmaceutical CO LJPC.QB | Director | filed 2013 - 2022 |
| Odonate Therapeutics, LLC ODT | Director | filed 2017 - 2020 |
| DMK Pharmaceuticals Corp DMK | Director | filed 2011 - 2013 |
| Intrabiotics Pharmaceuticals INC /DE RDEA | Director | filed 2008 - 2012 |
| Pure Bioscience, INC. PURE | Chief Financial Officer | filed 2011 - 2011 |
| Novadel Pharma INC nvd | Sr. VP, CFO and Secretary | filed 2010 - 2010 |
| Torreypines Therapeutics, Inc. TPTX | VP, Finance, CFO and Secy | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.